Sydney Lupkin
speaker
1,087 appearances
111 recordings
3 series
first heard Dec 2024
last heard 3d ago
Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 96 in all, peaking in Sep 2026 with 23.
Appearances
They have to have additional health conditions or a body mass index over 35.
People with Medicare will be able to get them for a copay of $50 a month.
State Medicaid programs will have to opt in, but the lower cost of the drugs to the government, $245 per patient per month, is something that I'm hearing will likely push them toward this.
Novo Nordisk and Eli Lilly's blockbuster obesity and type 2 diabetes drugs are the centerpiece of agreements announced by the White House.
The drugs, Ozempic, Wegovy, Zepound, and Manjaro, will be available to the government at lower prices and to Medicare beneficiaries for a $50 copay.
The deals expand Medicare and Medicaid access for some but not all patients with obesity, and the arrangements would expand discounts available to patients buying the drugs through TrumpRx.gov, a website that is expected to launch before the end of the year.
The companies also promised that if experimental obesity pills they are developing win FDA approval, they will cost $149 per month for their starting doses.
Sydney Lepkin, NPR News.
Novo Nordisk and Eli Lilly's blockbuster obesity and type 2 diabetes drugs are the centerpiece of agreements announced by the White House.
The drugs, Ozempic, Wegovy, Zepound, and Manjaro, will be available to the government at lower prices and to Medicare beneficiaries for a $50 copay.
The deals expand Medicare and Medicaid access for some but not all patients with obesity, and the arrangements would expand discounts available to patients buying the drugs through TrumpRx.gov, a website that is expected to launch before the end of the year.
The companies also promised that if experimental obesity pills they are developing win FDA approval, they will cost $149 per month for their starting doses.
Sydney Lepkin, NPR News.
Normally, companies can't advertise a drug to treat a condition it hasn't been FDA approved to treat.
But sponsored search results online aren't regulated the way television ads are.
Daniel Eisenkraft-Klein and his colleagues at Harvard Medical School looked at two years of paid search results for Ozempic.
According to a study published in JAMA Network Open, 11% of paid search phrases contain the word wait, even though Ozempic is only approved to treat type 2 diabetes.
Novo Nordisk says its paid search approach is standard and in compliance with U.S.
laws and regulations.
Sydney Lupkin, NPR News.
Showing 841–860 of 1,087 · page 43 of 55
← Previous
Next →